Alembic Pharma gets USFDA nod for cholesterol lowering drug

In a regulatory filing, Alembic Pharma said "it has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Fenofibrate capsules USP in the strengths of 67 mg, 134 mg and 200 mg.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news